![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Targeted Medical Pharma Inc (CE) | USOTC:TRGM | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0001 | 0.00 | 01:00:00 |
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours per response... 0.5 |
|
|
|
1. Name and Address of Reporting Person
*
Giffoni Kim |
2. Issuer Name
and
Ticker or Trading Symbol
Targeted Medical Pharma, Inc. [ TRGM ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__ X __ Director __ X __ 10% Owner __ X __ Officer (give title below) _____ Other (specify below) Chief Executive Officer |
C/O TARGETED MEDICAL PHARMA, INC., 2980 BEVERLY GLEN CIRCLE, SUITE 100 |
3. Date of Earliest Transaction
(MM/DD/YYYY)
|
|
LOS ANGELES, CA 90077 |
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person _ X _ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
||||||||||
1.Title of Security
(Instr. 3) |
2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code
(Instr. 8) |
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) |
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 11/24/2015 | S | 8580 | D | $0.015 | 2646668 | I | By Trust |
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) |
|||||||||||||||
1. Title of Derivate Security
(Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any |
4. Trans. Code
(Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
6. Date Exercisable and Expiration Date |
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) |
8. Price of Derivative Security
(Instr. 5) |
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Explanation of Responses: |
Remarks:
1. This Form 4 is filed jointly by Kim Giffoni, Olena B. Giffoni and the Giffoni Family Trust dated September 26, 2008 ("Giffoni Family Trust"). The Giffoni Family Trust is a 10% owner of the Company and Mr. Giffoni & Ms. Giffoni may be deemed to be 10% owners of the Company. Mr. Giffoni is the Chief Executive Officer and a Director of the Company. 2. These securities are owned indirectly by Mr. Giffoni and Ms. Giffoni by virtue of their being co-Trustees of the Giffoni Family Trust. Mr. Giffoni and Ms. Giffoni share voting and dispositive control with respect to the securities owned by the Giffoni Family Trust. Mr. Giffoni and Ms. Giffoni disclaim beneficial ownership of any shares owned by the Giffoni Family Trust except to the extent of their pecuniary interest therein. |
Reporting Owners
|
|||||
Reporting Owner Name / Address |
|
||||
Director | 10% Owner | Officer | Other | ||
Giffoni Kim
C/O TARGETED MEDICAL PHARMA, INC. 2980 BEVERLY GLEN CIRCLE, SUITE 100 LOS ANGELES, CA 90077 |
X | X | Chief Executive Officer |
|
|
Giffoni Family Trust Dated September 26 2008
245 PARADISE COVE ROAD MALIBU, CA 90265 |
|
X |
|
|
|
Giffoni Olena B.
245 PARADISE COVE ROAD C/O GIFFONI FAMILY TRUST MALIBU, CA 90265 |
|
X |
|
|
Signatures
|
||
Giffoni Family Trust Dated September26, 2008, /s/ Kim Giffoni, Co-Trustee | 11/24/2015 | |
** Signature of Reporting Person |
Date
|
|
/s/ Kim Giffoni | 11/24/2015 | |
** Signature of Reporting Person |
Date
|
|
/s/ Olena B. Giffoni | 11/24/2015 | |
** Signature of Reporting Person |
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year Targeted Medical Pharma (CE) Chart |
1 Month Targeted Medical Pharma (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions